| Cat. No. |
Product Name |
Information |
| PC-45638 |
Ribocil-C
FMN riboswitch inhibitor
|
Ribocil-C is a highly selective inhibitor of the FMN riboswitch that controls expression of de novo riboflavin (Vitamin B2) biosynthesis in Escherichia coli. |
| PC-45926 |
Moxifloxacin
Antibiotic
|
Moxifloxacin is a fourth-generation synthetic fluoroquinolone, broad-spectrum antibacterial agent that is active against both Gram-positive and Gram-negative bacteria; inhibits DNA gyrase and topoisomerase IV. |
| PC-45925 |
Moxifloxacin hydrochloride
Antibiotic, DNA gyrase inhibitor
|
Moxifloxacin hydrochloride (BAY 12-8039) is a fourth-generation synthetic fluoroquinolone, broad-spectrum antibacterial agent that is active against both Gram-positive and Gram-negative bacteria, inhibits DNA gyrase and topoisomerase IV. |
| PC-42665 |
Gatifloxacin
Bacterial DNA gyrase inhibitor
|
Gatifloxacin (PD 135432, AM1155) is a fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV. |
| PC-42048 |
Faropenem daloxate
Beta-lactam antibiotic
|
Faropenem daloxate (Faropenem medoxil) is a daloxate ester prodrug of Faropenem with broad-spectrum antibacterial activity against many gram-positive and gram-negative aerobes and anaerobes, a beta-lactam antibiotic. |
| PC-42714 |
Pretomanid
Mtb inhibitor
|
Pretomanid (PA-824) is an anti-tuberculosis agent that inhibits the synthesis of protein and cell wall lipid. |
| PC-28393 |
NDM-552
PBP2 inhibitor
|
NDM-552 is a Gram-positive selective antibacterial agent that potentially targets penicillin-binding protein 2 (PBP2)-associated cell wall biosynthesis, exhibits activity against Gram-positive pathogens including S. aureus, Enterococcus faecium, and Staphylococcus epidermidis with MIC of 1-2 ug/mL. |
| PC-28359 |
DksA inhibitor Compound 916
DksA inhibitor
|
DksA inhibitor Compound 916 is a small molecule inhibitor of Gram-negative bacteria DksA protein, inhibits DksA-mediated repression of rpsM in vitro transcription with IC50 of 928 nM, has MIC50 of 32 ug/mL against nontyphoidal S. enterica serovar Typhimurium strain 14028s and E. coli strain W3110. |
| PC-28303 |
VMP-7
Mtb GlgE inhibitor
|
VMP-7 is a small molecule inhibitor of Mycobacterium tuberculosis (M.tb) maltosyltransferase (GlgE), a key enzyme in the α-glucan biosynthesis pathway of M.tb, exhibits significant inhibitory activity against M.tb with MIC of 15.5 ug/mL. |
| PC-28263 |
Murepavadin TFA
Antibiotic, MRGPRX2 agonist
|
Murepavadin TFA (POL7080) is a highly potent, specific, macrocycle Pseudomonas antibiotic, activates mast cells via MRGPRX2 and MrgprB2. |
| PC-28185 |
MtbIMPDH inhibitor 31
Mtb GuaB inhibitor
|
MtbIMPDH inhibitor 31 is a potent, specific inhibitor of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase (Mtb GuaB, MtbIMPDH) with IC50 of 0.52 uM. |
| PC-28184 |
MtbIMPDH2 inhibitor P41
GuaB2 inhibitor
|
MtbIMPDH2 inhibitor P41 is a potent, specific inhibitor of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase (Mtb GuaB, MtbIMPDH) with Ki app of 17 nM for MtbIMPDH2ΔCBS, displays significant activity against Mtb strain H37Rv in minimal BSA-free medium with MIC of 5 uM. |